Roy C. Hardiman, Chief Business Officer at Principia Biopharma Inc. (PRNB), sold 10,000 shares at $61.62 ($612K) on 2020-06-12, disclosed to the SEC on 2020-06-15.
Open-market sale of $612k PRNB by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.90 | 1,595 | $96K | 15.6% |
| 2 | $59.90 | 1,595 | $96K | 15.6% |
| 3 | $61.62 | 2,542 | $157K | 25.6% |
| 4 | $61.62 | 2,542 | $157K | 25.6% |
| 5 | $62.13 | 863 | $54K | 8.8% |
| 6 | $62.13 | 863 |
| $54K |
| 8.8% |
| Total | $61.16 avg | 10,000 | $612K | 100% |
| Filing → |
| PRNB | SELL | 2019-12-13 | $494K | — | Filing → |